NAPPA appoints Chen Feng as Shanghai Regional Head
Boren Capital's founder joins NAPPA to deepen the alliance's footprint in China's leading biopharma and capital hub.
NAPPA has appointed Chen Feng as Shanghai Regional Head. The appointment deepens NAPPA’s footprint in China’s core pharma hubs and brings dedicated capacity for global deal structuring and pharmaceutical asset trading.
Background
Chen is Founder and CEO of Boren Capital, where he specializes in pharma investment and asset trading. He pioneered China’s first interactive pharmaceutical asset trading system, accelerating project matching from discovery through deal execution.
He brings 20+ years across senior leadership at Johnson & Johnson, Novartis, Pfizer, and Takeda, where he managed billion-dollar product lines across hematology, immunology, and cardiovascular. Education: medical degree; MBA, The Wharton School.
Focus areas
- Connecting Shanghai with North American and global innovation resources
- Clinical-to-commercial transformation of high-quality projects
- Cross-border asset trading and capital matching
- Strategic market management across hematology, immunology, and cardiovascular